CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating a topical anti-angiogenic therapy for hereditary hemorrhagic telangiectasia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-21